Home > Press Releases > Precision Medicine Market

Precision Medicine Market Likely to Surpass USD 302.8 Billion by 2035

Report Code: HC-73299  |  Published in: Dec 2025, By MarketGenics  |  Number of pages: 299
Get PDF
Buy

A significant study discovering the market avenues on, “Precision Medicine Market Size, Share & Trends Analysis Report by Technology/Platform Type (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarrays, Digital PCR, Single-Cell Analysis, Mass Spectrometry, Others), Product & Service, Application, Therapy Type, Biomarker Type, Sample Type, Patient Demographics, Disease Stage, End-users and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2026–2035” A holistic view of the market pathways in the precision medicine market underscores revenue acceleration through three key levers scalable product line extensions, high‑maturity strategic partnerships

Global Precision Medicine Market Forecast 2035:

According to the report, the global precision medicine market is projected to expand from USD 84.6 billion in 2025 to USD 302.8 billion by 2035, registering a CAGR of 13.6%, the highest during the forecast period. The precision medicine market is rapidly expanding throughout the globe due to the development of genomics, molecular diagnostics, and artificial intelligence-based data analytics. Precision medicine tailors’ therapies to each patient depending on their environment, lifestyle, and genetic characteristics and raises therapeutic efficacy and reducing adverse effects. The key uses are oncology, cardiovascular diseases, rare genetic diseases, and infectious diseases as oncology is the most frequently used in increasing use of targeted therapy, immunotherapy and biomarker-based therapy.

Next-generation sequencing (NGS), CRISPR-based gene editing, companion diagnostics, and bioinformatics platforms are some of the technological advances that are driving the embracement of personalized healthcare. The further supportive factors, which contribute to growth, include the escalating rates of chronic and lifestyle-related diseases, the growing awareness of personal approaches to treatment, and the significant investment in research and development in the healthcare industry.

The accuracy of the precision medicine space is also being reinforced through strategic collaborations, partnerships and the development of novel therapies that are progressively making treatments more effective, safer, and personalized, to patient-specific needs which ultimately will transform the modern healthcare provision.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Precision Medicine Market”

The precision medicine market is being driven by increased awareness among healthcare providers and patients. With the increased awareness of the advantages of tailored treatment plans, more clinicians are incorporating genetic testing, biomarker analysis, and molecular diagnostics into regular treatment. At the same time, patients are increasingly educated in individual treatments, which are more effective, cause fewer side effects, and do not lead to inappropriate life quality. This trend of patient-centric care is increasing the pace of adoption of precision medicine in various therapeutic domains, particularly in oncology and rare diseases, which leads to market expansion.

Precision medicine presents serious privacy and security issues in the management of sensitive genetic and health information. Patient trust can be compromised by the risks of data breach, unauthorized access, and misuse of the personal health information. Moreover, adherence to tough data protection laws, like the HIPAA and GDPR, also complicate the life of healthcare providers and companies and may slow down their adoption and raise costs in order to operate, acting as a primary inhibitor of market expansion.

The increasing indecencies of rare genetic diseases and different types of cancers creates a significant opportunity to the precision medicine market. Specific interventions and biomarker-based treatments allow more effective and personalized treatment that enhances patient outcomes and limits the side effects. The use of precision medicine solutions in treating these conditions is evolving by increasing investment in research and clinical trials, as well as by improving molecular diagnostics, which has created a large market growth opportunity.

Expansion of Global Precision Medicine Market

“Innovation, and public funding propel the global precision medicine market expansion”

  • The precision medicine market is expanding rapidly worldwide, as the world is witnessing technological advances in genomics and molecular diagnostics, next-generation sequencing (NGS), and AI-based bioinformatics, as well as, CRISPR-based gene editing, that lead to tailored medicine, better therapeutic responses, and better disease management in oncology, rare diseases, cardiovascular disorders, and other targeted disease treatments. To give an example, Signios Bio introduced an artificial intelligence-based bioinformatics and sophisticated multiomics platform combining genomics, transcriptomics, proteomics, and spatial biology to hasten the research and drug discovery in precision medicine.
  • The rapid expansion of the precision medicine market is being accelerated through government incentives and heavy investment by companies to accelerate innovation, research and expansive clinical use. As an example, in October 2025 the California Initiative to Advance Precision Medicine (CIAPM) announced the publication of a new Request for Applications with up to US 8.3 million of funds to fund representative precision medicine research focused on addressing health-equity in genomics and personalized treatment.

Regional Analysis of Global Precision Medicine Market

  • The precision medicine market is dominated by North America, as they have a high level of healthcare infrastructure, a heavy dependence on next-generation sequencing and molecular diagnostics, a large volume of government funding, and research and development capability. The early adoption of AI-assisted bioinformatics, and the rising acceptance among clinicians and patients of the concept of personalized therapies enhance further the dominance of the region in the domain of adoption, innovation, and integration of multiple therapeutic domains in the field of precision medicine.
  • The Asia Pacific is projected to experience the highest growth rate in the precision medicine market due to the increasing healthcare spending, growth in molecular diagnostics facility and growing government efforts to promote personalized healthcare. This is being adopted by rapid urbanization, increased prevalence of chronic and genetic diseases, and better access to more sophisticated sequencing and bioinformatics technology. Also, the partnerships between local research institutions and international precision medicine companies are boosting innovation and clinical adoption both in the region.

Prominent players operating in the global precision medicine market are 10x Genomics, Inc., Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Exact Sciences Corporation, Foundation Medicine, Inc., GE HealthCare, Guardant Health, Inc., Illumina, Inc., Invitae Corporation, Myriad Genetics, Inc., NanoString Technologies, Inc., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Roche Holding AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Other Key Players.

The global precision medicine market has been segmented as follows:

Global Precision Medicine Market Analysis, By Technology/Platform Type

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Microarrays
  • Digital PCR
  • Single-Cell Analysis
  • Mass Spectrometry
  • Others

Global Precision Medicine Market Analysis, By Product & Service

  • Consumables
  • Instruments
  • Software & Bioinformatics
  • Services (Testing, Consulting, Integration)

Global Precision Medicine Market Analysis, By Application

  • Oncology
    • Breast Cancer
    • Lung Cancer
    • Leukemia
    • Other Cancers
  • Cardiovascular Diseases
  • Central Nervous System Disorders
  • Respiratory Diseases
  • Immunology
  • Infectious Diseases
  • Rare Diseases
  • Metabolic Disorders

Global Precision Medicine Market Analysis, By Therapy Type

  • Targeted Therapy
  • Gene Therapy
  • Cell Therapy
  • Immunotherapy
  • Pharmacogenomics-based Therapy

Global Precision Medicine Market Analysis, By Sample Type

  • Blood
  • Tissue
  • Saliva
  • Urine
  • Other Body Fluids

Global Precision Medicine Market Analysis, By Patient Demographics

  • Pediatric
  • Adult
  • Geriatric

Global Precision Medicine Market Analysis, By Disease Stage

  • Early Detection/Screening
  • Diagnosis
  • Prognosis
  • Treatment Selection
  • Monitoring & Follow-up

Global Precision Medicine Market Analysis, By End-users

  • Hospitals & Clinics
  • Diagnostic Centers & Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutions
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

Global Precision Medicine Market Analysis, By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Precision Medicine Market Outlook
      • 2.1.1. Precision Medicine Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
    • 3.4. Trade Analysis
      • 3.4.1. Import & Export Analysis, 2025
      • 3.4.2. Top Importing Countries
      • 3.4.3. Top Exporting Countries
    • 3.5. Trump Tariff Impact Analysis
      • 3.5.1. Manufacturer
        • 3.5.1.1. Based on the component & Raw material
      • 3.5.2. Supply Chain
      • 3.5.3. End Consumer
    • 3.6. Raw Material Analysis
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising prevalence of chronic and rare diseases
        • 4.1.1.2. Advancements in genomics, NGS, and AI technologies
        • 4.1.1.3. Growing government and private investments in personalized healthcare
      • 4.1.2. Restraints
        • 4.1.2.1. High cost of genomic testing and targeted therapies
        • 4.1.2.2. Data privacy and security concerns in genetic information handling
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
      • 4.4.1. Raw Material Suppliers
      • 4.4.2. Manufacturers and Technology Providers
      • 4.4.3. Distributors
      • 4.4.4. End Users
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Precision Medicine Market Demand
      • 4.7.1. Historical Market Size –Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size –Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Precision Medicine Market Analysis, By Technology/Platform Type
    • 6.1. Key Segment Analysis
    • 6.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, By Technology/Platform Type, 2021-2035
      • 6.2.1. Next-Generation Sequencing (NGS)
      • 6.2.2. Polymerase Chain Reaction (PCR)
      • 6.2.3. Immunohistochemistry (IHC)
      • 6.2.4. In Situ Hybridization (ISH)
      • 6.2.5. Microarrays
      • 6.2.6. Digital PCR
      • 6.2.7. Single-Cell Analysis
      • 6.2.8. Mass Spectrometry
      • 6.2.9. Others
  • 7. Global Precision Medicine Market Analysis, By Product & Service
    • 7.1. Key Segment Analysis
    • 7.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, By Product & Service, 2021-2035
      • 7.2.1. Consumables
      • 7.2.2. Instruments
      • 7.2.3. Software & Bioinformatics
      • 7.2.4. Services (Testing, Consulting, Integration)
  • 8. Global Precision Medicine Market Analysis,By Application
    • 8.1. Key Segment Analysis
    • 8.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, By Application, 2021-2035
      • 8.2.1. Oncology
        • 8.2.1.1. Breast Cancer
        • 8.2.1.2. Lung Cancer
        • 8.2.1.3. Leukemia
        • 8.2.1.4. Other Cancers
      • 8.2.2. Cardiovascular Diseases
      • 8.2.3. Central Nervous System Disorders
      • 8.2.4. Respiratory Diseases
      • 8.2.5. Immunology
      • 8.2.6. Infectious Diseases
      • 8.2.7. Rare Diseases
      • 8.2.8. Metabolic Disorders
  • 9. Global Precision Medicine Market Analysis, By Therapy Type
    • 9.1. Key Segment Analysis
    • 9.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, By Therapy Type, 2021-2035
      • 9.2.1. Targeted Therapy
      • 9.2.2. Gene Therapy
      • 9.2.3. Cell Therapy
      • 9.2.4. Immunotherapy
      • 9.2.5. Pharmacogenomics-based Therapy
  • 10. Global Precision Medicine Market Analysis, By Biomarker Type
    • 10.1. Key Segment Analysis
    • 10.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, By Biomarker Type, 2021-2035
      • 10.2.1. Genetic Biomarkers
      • 10.2.2. Protein Biomarkers
      • 10.2.3. Metabolic Biomarkers
      • 10.2.4. Imaging Biomarkers
  • 11. Global Precision Medicine Market Analysis, By Sample Type
    • 11.1. Key Segment Analysis
    • 11.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, By Sample Type, 2021-2035
      • 11.2.1. Blood
      • 11.2.2. Tissue
      • 11.2.3. Saliva
      • 11.2.4. Urine
      • 11.2.5. Other Body Fluids
  • 12. Global Precision Medicine Market Analysis, By Patient Demographics
    • 12.1. Key Segment Analysis
    • 12.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, By Patient Demographics, 2021-2035
      • 12.2.1. Pediatric
      • 12.2.2. Adult
      • 12.2.3. Geriatric
  • 13. Global Precision Medicine Market Analysis, By Disease Stage
    • 13.1. Key Segment Analysis
    • 13.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, By Disease Stage, 2021-2035
      • 13.2.1. Early Detection/Screening
      • 13.2.2. Diagnosis
      • 13.2.3. Prognosis
      • 13.2.4. Treatment Selection
      • 13.2.5. Monitoring & Follow-up
  • 14. Global Precision Medicine Market Analysis, By End-users
    • 14.1. Key Segment Analysis
    • 14.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, By End-users, 2021-2035
      • 14.2.1. Hospitals & Clinics
      • 14.2.2. Diagnostic Centers & Laboratories
      • 14.2.3. Pharmaceutical & Biotechnology Companies
      • 14.2.4. Research & Academic Institutions
      • 14.2.5. Ambulatory Surgical Centers
      • 14.2.6. Home Care Settings
      • 14.2.7. Others
  • 15. Global Precision Medicine Market Analysis and Forecasts, by Region
    • 15.1. Key Findings
    • 15.2. Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 15.2.1. North America
      • 15.2.2. Europe
      • 15.2.3. Asia Pacific
      • 15.2.4. Middle East
      • 15.2.5. Africa
      • 15.2.6. South America
  • 16. North America Precision Medicine Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. North America Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Technology/Platform Type
      • 16.3.2. Product & Service
      • 16.3.3. Application
      • 16.3.4. Therapy Type
      • 16.3.5. Biomarker Type
      • 16.3.6. Sample Type
      • 16.3.7. Patient Demographics
      • 16.3.8. Disease Stage
      • 16.3.9. End-users
      • 16.3.10. Country
        • 16.3.10.1. USA
        • 16.3.10.2. Canada
        • 16.3.10.3. Mexico
    • 16.4. USA Precision Medicine Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Technology/Platform Type
      • 16.4.3. Product & Service
      • 16.4.4. Application
      • 16.4.5. Therapy Type
      • 16.4.6. Biomarker Type
      • 16.4.7. Sample Type
      • 16.4.8. Patient Demographics
      • 16.4.9. Disease Stage
      • 16.4.10. End-users
    • 16.5. Canada Precision Medicine Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Technology/Platform Type
      • 16.5.3. Product & Service
      • 16.5.4. Application
      • 16.5.5. Therapy Type
      • 16.5.6. Biomarker Type
      • 16.5.7. Sample Type
      • 16.5.8. Patient Demographics
      • 16.5.9. Disease Stage
      • 16.5.10. End-users
    • 16.6. Mexico Precision Medicine Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Technology/Platform Type
      • 16.6.3. Product & Service
      • 16.6.4. Application
      • 16.6.5. Therapy Type
      • 16.6.6. Biomarker Type
      • 16.6.7. Sample Type
      • 16.6.8. Patient Demographics
      • 16.6.9. Disease Stage
      • 16.6.10. End-users
  • 17. Europe Precision Medicine Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Europe Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Technology/Platform Type
      • 17.3.2. Product & Service
      • 17.3.3. Application
      • 17.3.4. Therapy Type
      • 17.3.5. Biomarker Type
      • 17.3.6. Sample Type
      • 17.3.7. Patient Demographics
      • 17.3.8. Disease Stage
      • 17.3.9. End-users
      • 17.3.10. Country
        • 17.3.10.1. Germany
        • 17.3.10.2. United Kingdom
        • 17.3.10.3. France
        • 17.3.10.4. Italy
        • 17.3.10.5. Spain
        • 17.3.10.6. Netherlands
        • 17.3.10.7. Nordic Countries
        • 17.3.10.8. Poland
        • 17.3.10.9. Russia & CIS
        • 17.3.10.10. Rest of Europe
    • 17.4. Germany Precision Medicine Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Technology/Platform Type
      • 17.4.3. Product & Service
      • 17.4.4. Application
      • 17.4.5. Therapy Type
      • 17.4.6. Biomarker Type
      • 17.4.7. Sample Type
      • 17.4.8. Patient Demographics
      • 17.4.9. Disease Stage
      • 17.4.10. End-users
    • 17.5. United Kingdom Precision Medicine Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Technology/Platform Type
      • 17.5.3. Product & Service
      • 17.5.4. Application
      • 17.5.5. Therapy Type
      • 17.5.6. Biomarker Type
      • 17.5.7. Sample Type
      • 17.5.8. Patient Demographics
      • 17.5.9. Disease Stage
      • 17.5.10. End-users
    • 17.6. France Precision Medicine Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Technology/Platform Type
      • 17.6.3. Product & Service
      • 17.6.4. Application
      • 17.6.5. Therapy Type
      • 17.6.6. Biomarker Type
      • 17.6.7. Sample Type
      • 17.6.8. Patient Demographics
      • 17.6.9. Disease Stage
      • 17.6.10. End-users
    • 17.7. Italy Precision Medicine Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Technology/Platform Type
      • 17.7.3. Product & Service
      • 17.7.4. Application
      • 17.7.5. Therapy Type
      • 17.7.6. Biomarker Type
      • 17.7.7. Sample Type
      • 17.7.8. Patient Demographics
      • 17.7.9. Disease Stage
      • 17.7.10. End-users
    • 17.8. Spain Precision Medicine Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Technology/Platform Type
      • 17.8.3. Product & Service
      • 17.8.4. Application
      • 17.8.5. Therapy Type
      • 17.8.6. Biomarker Type
      • 17.8.7. Sample Type
      • 17.8.8. Patient Demographics
      • 17.8.9. Disease Stage
      • 17.8.10. End-users
    • 17.9. Netherlands Precision Medicine Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Technology/Platform Type
      • 17.9.3. Product & Service
      • 17.9.4. Application
      • 17.9.5. Therapy Type
      • 17.9.6. Biomarker Type
      • 17.9.7. Sample Type
      • 17.9.8. Patient Demographics
      • 17.9.9. Disease Stage
      • 17.9.10. End-users
    • 17.10. Nordic Countries Precision Medicine Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Technology/Platform Type
      • 17.10.3. Product & Service
      • 17.10.4. Application
      • 17.10.5. Therapy Type
      • 17.10.6. Biomarker Type
      • 17.10.7. Sample Type
      • 17.10.8. Patient Demographics
      • 17.10.9. Disease Stage
      • 17.10.10. End-users
    • 17.11. Poland Precision Medicine Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Technology/Platform Type
      • 17.11.3. Product & Service
      • 17.11.4. Application
      • 17.11.5. Therapy Type
      • 17.11.6. Biomarker Type
      • 17.11.7. Sample Type
      • 17.11.8. Patient Demographics
      • 17.11.9. Disease Stage
      • 17.11.10. End-users
    • 17.12. Russia & CIS Precision Medicine Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Technology/Platform Type
      • 17.12.3. Product & Service
      • 17.12.4. Application
      • 17.12.5. Therapy Type
      • 17.12.6. Biomarker Type
      • 17.12.7. Sample Type
      • 17.12.8. Patient Demographics
      • 17.12.9. Disease Stage
      • 17.12.10. End-users
    • 17.13. Rest of Europe Precision Medicine Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Technology/Platform Type
      • 17.13.3. Product & Service
      • 17.13.4. Application
      • 17.13.5. Therapy Type
      • 17.13.6. Biomarker Type
      • 17.13.7. Sample Type
      • 17.13.8. Patient Demographics
      • 17.13.9. Disease Stage
      • 17.13.10. End-users
  • 18. Asia Pacific Precision Medicine Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Asia Pacific Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Technology/Platform Type
      • 18.3.2. Product & Service
      • 18.3.3. Application
      • 18.3.4. Therapy Type
      • 18.3.5. Biomarker Type
      • 18.3.6. Sample Type
      • 18.3.7. Patient Demographics
      • 18.3.8. Disease Stage
      • 18.3.9. End-users
      • 18.3.10. Country
        • 18.3.10.1. China
        • 18.3.10.2. India
        • 18.3.10.3. Japan
        • 18.3.10.4. South Korea
        • 18.3.10.5. Australia and New Zealand
        • 18.3.10.6. Indonesia
        • 18.3.10.7. Malaysia
        • 18.3.10.8. Thailand
        • 18.3.10.9. Vietnam
        • 18.3.10.10. Rest of Asia Pacific
    • 18.4. China Precision Medicine Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Technology/Platform Type
      • 18.4.3. Product & Service
      • 18.4.4. Application
      • 18.4.5. Therapy Type
      • 18.4.6. Biomarker Type
      • 18.4.7. Sample Type
      • 18.4.8. Patient Demographics
      • 18.4.9. Disease Stage
      • 18.4.10. End-users
    • 18.5. India Precision Medicine Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Technology/Platform Type
      • 18.5.3. Product & Service
      • 18.5.4. Application
      • 18.5.5. Therapy Type
      • 18.5.6. Biomarker Type
      • 18.5.7. Sample Type
      • 18.5.8. Patient Demographics
      • 18.5.9. Disease Stage
      • 18.5.10. End-users
    • 18.6. Japan Precision Medicine Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Technology/Platform Type
      • 18.6.3. Product & Service
      • 18.6.4. Application
      • 18.6.5. Therapy Type
      • 18.6.6. Biomarker Type
      • 18.6.7. Sample Type
      • 18.6.8. Patient Demographics
      • 18.6.9. Disease Stage
      • 18.6.10. End-users
    • 18.7. South Korea Precision Medicine Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Technology/Platform Type
      • 18.7.3. Product & Service
      • 18.7.4. Application
      • 18.7.5. Therapy Type
      • 18.7.6. Biomarker Type
      • 18.7.7. Sample Type
      • 18.7.8. Patient Demographics
      • 18.7.9. Disease Stage
      • 18.7.10. End-users
    • 18.8. Australia and New Zealand Precision Medicine Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Technology/Platform Type
      • 18.8.3. Product & Service
      • 18.8.4. Application
      • 18.8.5. Therapy Type
      • 18.8.6. Biomarker Type
      • 18.8.7. Sample Type
      • 18.8.8. Patient Demographics
      • 18.8.9. Disease Stage
      • 18.8.10. End-users
    • 18.9. Indonesia Precision Medicine Market
      • 18.9.1. Country Segmental Analysis
      • 18.9.2. Technology/Platform Type
      • 18.9.3. Product & Service
      • 18.9.4. Application
      • 18.9.5. Therapy Type
      • 18.9.6. Biomarker Type
      • 18.9.7. Sample Type
      • 18.9.8. Patient Demographics
      • 18.9.9. Disease Stage
      • 18.9.10. End-users
    • 18.10. Malaysia Precision Medicine Market
      • 18.10.1. Country Segmental Analysis
      • 18.10.2. Technology/Platform Type
      • 18.10.3. Product & Service
      • 18.10.4. Application
      • 18.10.5. Therapy Type
      • 18.10.6. Biomarker Type
      • 18.10.7. Sample Type
      • 18.10.8. Patient Demographics
      • 18.10.9. Disease Stage
      • 18.10.10. End-users
    • 18.11. Thailand Precision Medicine Market
      • 18.11.1. Country Segmental Analysis
      • 18.11.2. Technology/Platform Type
      • 18.11.3. Product & Service
      • 18.11.4. Application
      • 18.11.5. Therapy Type
      • 18.11.6. Biomarker Type
      • 18.11.7. Sample Type
      • 18.11.8. Patient Demographics
      • 18.11.9. Disease Stage
      • 18.11.10. End-users
    • 18.12. Vietnam Precision Medicine Market
      • 18.12.1. Country Segmental Analysis
      • 18.12.2. Technology/Platform Type
      • 18.12.3. Product & Service
      • 18.12.4. Application
      • 18.12.5. Therapy Type
      • 18.12.6. Biomarker Type
      • 18.12.7. Sample Type
      • 18.12.8. Patient Demographics
      • 18.12.9. Disease Stage
      • 18.12.10. End-users
    • 18.13. Rest of Asia Pacific Precision Medicine Market
      • 18.13.1. Country Segmental Analysis
      • 18.13.2. Technology/Platform Type
      • 18.13.3. Product & Service
      • 18.13.4. Application
      • 18.13.5. Therapy Type
      • 18.13.6. Biomarker Type
      • 18.13.7. Sample Type
      • 18.13.8. Patient Demographics
      • 18.13.9. Disease Stage
      • 18.13.10. End-users
  • 19. Middle East Precision Medicine Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Middle East Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Technology/Platform Type
      • 19.3.2. Product & Service
      • 19.3.3. Application
      • 19.3.4. Therapy Type
      • 19.3.5. Biomarker Type
      • 19.3.6. Sample Type
      • 19.3.7. Patient Demographics
      • 19.3.8. Disease Stage
      • 19.3.9. End-users
      • 19.3.10. Country
        • 19.3.10.1. Turkey
        • 19.3.10.2. UAE
        • 19.3.10.3. Saudi Arabia
        • 19.3.10.4. Israel
        • 19.3.10.5. Rest of Middle East
    • 19.4. Turkey Precision Medicine Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Technology/Platform Type
      • 19.4.3. Product & Service
      • 19.4.4. Application
      • 19.4.5. Therapy Type
      • 19.4.6. Biomarker Type
      • 19.4.7. Sample Type
      • 19.4.8. Patient Demographics
      • 19.4.9. Disease Stage
      • 19.4.10. End-users
    • 19.5. UAE Precision Medicine Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Technology/Platform Type
      • 19.5.3. Product & Service
      • 19.5.4. Application
      • 19.5.5. Therapy Type
      • 19.5.6. Biomarker Type
      • 19.5.7. Sample Type
      • 19.5.8. Patient Demographics
      • 19.5.9. Disease Stage
      • 19.5.10. End-users
    • 19.6. Saudi Arabia Precision Medicine Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Technology/Platform Type
      • 19.6.3. Product & Service
      • 19.6.4. Application
      • 19.6.5. Therapy Type
      • 19.6.6. Biomarker Type
      • 19.6.7. Sample Type
      • 19.6.8. Patient Demographics
      • 19.6.9. Disease Stage
      • 19.6.10. End-users
    • 19.7. Israel Precision Medicine Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Technology/Platform Type
      • 19.7.3. Product & Service
      • 19.7.4. Application
      • 19.7.5. Therapy Type
      • 19.7.6. Biomarker Type
      • 19.7.7. Sample Type
      • 19.7.8. Patient Demographics
      • 19.7.9. Disease Stage
      • 19.7.10. End-users
    • 19.8. Rest of Middle East Precision Medicine Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Technology/Platform Type
      • 19.8.3. Product & Service
      • 19.8.4. Application
      • 19.8.5. Therapy Type
      • 19.8.6. Biomarker Type
      • 19.8.7. Sample Type
      • 19.8.8. Patient Demographics
      • 19.8.9. Disease Stage
      • 19.8.10. End-users
  • 20. Africa Precision Medicine Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. Africa Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Technology/Platform Type
      • 20.3.2. Product & Service
      • 20.3.3. Application
      • 20.3.4. Therapy Type
      • 20.3.5. Biomarker Type
      • 20.3.6. Sample Type
      • 20.3.7. Patient Demographics
      • 20.3.8. Disease Stage
      • 20.3.9. End-users
      • 20.3.10. Country
        • 20.3.10.1. South Africa
        • 20.3.10.2. Egypt
        • 20.3.10.3. Nigeria
        • 20.3.10.4. Algeria
        • 20.3.10.5. Rest of Africa
    • 20.4. South Africa Precision Medicine Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Technology/Platform Type
      • 20.4.3. Product & Service
      • 20.4.4. Application
      • 20.4.5. Therapy Type
      • 20.4.6. Biomarker Type
      • 20.4.7. Sample Type
      • 20.4.8. Patient Demographics
      • 20.4.9. Disease Stage
      • 20.4.10. End-users
    • 20.5. Egypt Precision Medicine Market
      • 20.5.1. Procedure Type
      • 20.5.2. Technology/Platform Type
      • 20.5.3. Product & Service
      • 20.5.4. Application
      • 20.5.5. Therapy Type
      • 20.5.6. Biomarker Type
      • 20.5.7. Sample Type
      • 20.5.8. Patient Demographics
      • 20.5.9. Disease Stage
      • 20.5.10. End-users
    • 20.6. Nigeria Precision Medicine Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Technology/Platform Type
      • 20.6.3. Product & Service
      • 20.6.4. Application
      • 20.6.5. Therapy Type
      • 20.6.6. Biomarker Type
      • 20.6.7. Sample Type
      • 20.6.8. Patient Demographics
      • 20.6.9. Disease Stage
      • 20.6.10. End-users
    • 20.7. Algeria Precision Medicine Market
      • 20.7.1. Country Segmental Analysis
      • 20.7.2. Technology/Platform Type
      • 20.7.3. Product & Service
      • 20.7.4. Application
      • 20.7.5. Therapy Type
      • 20.7.6. Biomarker Type
      • 20.7.7. Sample Type
      • 20.7.8. Patient Demographics
      • 20.7.9. Disease Stage
      • 20.7.10. End-users
    • 20.8. Rest of Africa Precision Medicine Market
      • 20.8.1. Country Segmental Analysis
      • 20.8.2. Technology/Platform Type
      • 20.8.3. Product & Service
      • 20.8.4. Application
      • 20.8.5. Therapy Type
      • 20.8.6. Biomarker Type
      • 20.8.7. Sample Type
      • 20.8.8. Patient Demographics
      • 20.8.9. Disease Stage
      • 20.8.10. End-users
  • 21. South America Precision Medicine Market Analysis
    • 21.1. Key Segment Analysis
    • 21.2. Regional Snapshot
    • 21.3. South America Precision Medicine Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 21.3.1. Technology/Platform Type
      • 21.3.2. Product & Service
      • 21.3.3. Application
      • 21.3.4. Therapy Type
      • 21.3.5. Biomarker Type
      • 21.3.6. Sample Type
      • 21.3.7. Patient Demographics
      • 21.3.8. Disease Stage
      • 21.3.9. End-users
      • 21.3.10. Country
        • 21.3.10.1. Brazil
        • 21.3.10.2. Argentina
        • 21.3.10.3. Rest of South America
    • 21.4. Brazil Precision Medicine Market
      • 21.4.1. Country Segmental Analysis
      • 21.4.2. Technology/Platform Type
      • 21.4.3. Product & Service
      • 21.4.4. Application
      • 21.4.5. Therapy Type
      • 21.4.6. Biomarker Type
      • 21.4.7. Sample Type
      • 21.4.8. Patient Demographics
      • 21.4.9. Disease Stage
      • 21.4.10. End-users
    • 21.5. Argentina Precision Medicine Market
      • 21.5.1. Country Segmental Analysis
      • 21.5.2. Technology/Platform Type
      • 21.5.3. Product & Service
      • 21.5.4. Application
      • 21.5.5. Therapy Type
      • 21.5.6. Biomarker Type
      • 21.5.7. Sample Type
      • 21.5.8. Patient Demographics
      • 21.5.9. Disease Stage
      • 21.5.10. End-users
    • 21.6. Rest of South America Precision Medicine Market
      • 21.6.1. Country Segmental Analysis
      • 21.6.2. Technology/Platform Type
      • 21.6.3. Product & Service
      • 21.6.4. Application
      • 21.6.5. Therapy Type
      • 21.6.6. Biomarker Type
      • 21.6.7. Sample Type
      • 21.6.8. Patient Demographics
      • 21.6.9. Disease Stage
      • 21.6.10. End-users
  • 22. Key Players/ Company Profile
    • 22.1. 10x Genomics, Inc.
      • 22.1.1. Company Details/ Overview
      • 22.1.2. Company Financials
      • 22.1.3. Key Customers and Competitors
      • 22.1.4. Business/ Industry Portfolio
      • 22.1.5. Product Portfolio/ Specification Details
      • 22.1.6. Pricing Data
      • 22.1.7. Strategic Overview
      • 22.1.8. Recent Developments
    • 22.2. Abbott Laboratories
    • 22.3. Agilent Technologies, Inc.
    • 22.4. Bio-Rad Laboratories, Inc.
    • 22.5. Danaher Corporation
    • 22.6. Exact Sciences Corporation
    • 22.7. Foundation Medicine, Inc.
    • 22.8. GE HealthCare
    • 22.9. Guardant Health, Inc.
    • 22.10. Illumina, Inc.
    • 22.11. Invitae Corporation
    • 22.12. Myriad Genetics, Inc.
    • 22.13. NanoString Technologies, Inc.
    • 22.14. Oxford Nanopore Technologies
    • 22.15. Pacific Biosciences of California, Inc.
    • 22.16. PerkinElmer, Inc.
    • 22.17. QIAGEN N.V.
    • 22.18. Roche Holding AG
    • 22.19. Siemens Healthineers AG
    • 22.20. Thermo Fisher Scientific Inc.
    • 22.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation